Johns Hopkins Medicine was awarded over $18 million to lead a multi-institutional approach to developing a novel extracorporeal membrane oxygenation (ECMO) and advanced life-support system device. The ...
He developed extracorporeal membrane oxygenation, or ECMO, a treatment that can sustain patients whose hearts and lungs are failing — for days or weeks or longer. By Jeré Longman Robert H. Bartlett, a ...
LVAD therapy is a life-saving breakthrough for end-stage heart failure patients in India. Discover how Dr. Vishal Khullar ...